Skip to main content
Show — Main navigation
Hide — Main navigation
Submit an Article
Managing Interventional Oncology in the time of COVID-19
April 07, 2020
Don't miss this special live presentation on Managing Interventional Oncology in the Time of COVID-19, featuring insight by #CIO2020 Course Director, Edward Kim, MD.
Comparing Stable vs Unstable Emulsions for Chemoembolization
July 10, 2018
Researchers conducted a prospective, single-center, double-blind randomized phase III trial that compared stable and unstable water-in-oil emulsions for chemoembolization.
Study Compares RFA vs TACE for Caudate HCC
June 28, 2018
The study compared results for patients with caudate HCC who were treated with RFA vs TACE.
TACE and Sorafenib Combination Shows Promise for Advanced HCC
June 26, 2018
The combination of sorafenib and transarterial chemoembolization (TACE) for patients with advanced HCC seems feasible and promising, researchers reported.
Percutaneous Cryoblation Ablation May Be a Treatment Option for Patients With Solitary, Sporadic RCC
June 15, 2018
Percutaneous cryoblation ablation may be a reasonable treatment option for patients with clinical stage T1a papillary on renal cell carcinoma (pRCC) and clear-cell RCC (ccRCC), especially for patients with (pRCC).
Combined Microwave Ablation and Cementoplasty Eases Pain in Extra-Spinal Metastases
June 14, 2018
The combination of microwave ablation and cementoplasty may offer patients with extra-spinal metastases a minimally invasive option for pain reduction
Could Adjuvant Inhibition of Cancer Stem Cells Improve Local Therapy Outcomes?
June 12, 2018
Researchers hypothesized that inhibition of cancer stem cells in HCC may improve the efficacy of percutaneous thermal ablation, TACE, and TAE.
Does Primary Colorectal Tumor Site Affect Outcomes with RFA?
June 05, 2018
The researchers compared outcomes for patients undergoing RFA for primary left-side vs right-side colorectal cancer.
Comparing TACE Plus Iodine-125 With TACE Alone
May 31, 2018
An analysis of 9 studies compared TACE plus iodine-125 seed with TACE alone for patients with HCC.
Study Examines Ten-Year Trends in TARE for HCC
May 29, 2018
Use of TARE for HCC has been increasing over the past decade, according to a study published in JVIR.
Y-90: Prognosis Predictors for Patients with Liver Metastases from Colorectal Cancer
May 22, 2018
Analysis of several pretreatment factors may help predict the prognosis of patients treated with Y-90 radioembolization for liver metastases from colorectal cancer.
Back to Top